Regional brain changes in [3H]SCH 23390 binding to dopamine D1 receptors after long-term haloperidol treatment: Lack of correspondence with the development of vacuous chewing movements

Behavioural Brain Research

Volumn 90, Issue 2, 1998, Pages 125-132

  Sasaki, Tsukasa ^a   Kennedy, James L ^a   Nobrega, José N ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Animal model; Chronic haloperidol; Dopamine D1 receptor autoradiography; Neuroleptics; Tardive dyskinesia

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; HALOPERIDOL; HALOPERIDOL DECANOATE; NEUROLEPTIC AGENT; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CAUDATE NUCLEUS; CONTROLLED STUDY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MASTICATION; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; PUTAMEN; RAT; SUBSTANTIA NIGRA; TARDIVE DYSKINESIA;

EID: 0031891352     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)00092-2     Document Type: Article

References (27)

1. Delfs M.P., Kelley A.E. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Neuroscience. 39:1990;11-20.
2. Diana M., Collu M. D1 receptors mediated vacuous chewing in the rat: a model of tardive dyskinesia. Pharmacol. Res. 22:1990;45.
3. Egan M.F., Hurd Y., Hyde T.M., Weinberger D.R., Wyatt R.J., Kleinman J.E. Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias. Synapse. 18:1994;178-189.
4. Gunne L.M., Growdon J., Glaeser B. Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology. 77:1982;134-139.
5. Hess E.J., Norman A.B., Creese I. Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors. J. Neurosci. 8:1988;2361-2370.
6. Johansson P., Levin E., Gunne L., Ellison G. Opposite effects of a D1 and a D2 agonist on oral movements. Life Sci. 39:1987;29-35.
7. Knable M.B., Hyde T.M., Egan M.F., Tosayali M.T., Wyatt R.J., Kleinman J.E. Quantitative autoradiography of striatal D1, D2 and re-uptake sites in rats with vacuous chewing movements. Brain Res. 646:1994;217-222.
8. Koshikawa N., Aoki S., Hiruta M., Tomiyama K., Kobayashi M., Tsuboi Y., Iwata K., Sumino R., Stephenson J.D. Effects of intrastriatal injections of selective dopamine D-1 and D-2 agonists and antagonists on jaw movements of rats. Eur. J. Pharmacol. 163:1989;227-236.
9. Koshikawa N., Koshikawa F., Tomiyama K., de Beltrán K.K., Kamimura F., Kobayashi M. Effects of dopamine D1 and D2 agonists and antagonists injected into the nucleus accumbens and globus pallidus on jaw movements of rats. Eur. J. Pharmacol. 182:1990;375-380.
10. Laruelle M., Jaskiw G.E., Lipska B.K., Kolachana B., Casanova M.F., Kleinman J.E., Weinberger D.R. D1 and D2 receptor modulation in rat striatum and nucleus accumbens after subchronic and chronic haloperidol treatment. Brain Res. 575:1992;47-56.
11. Levin E.D., See R.E., South D. Effects of dopamine D1 and D2 receptor antagonists on oral activity in rats. Pharmacol. Biochem. Behav. 34:1989;43-48.
12. Mackenzie R.G., Zigmond M.J. Chronic neuroleptic treatment increases D2 but not D1 receptors in rat striatum. Eur. J. Pharmacol. 113:1985;159-165.
13. Morelli M., Fenu S., Di Chiara G. Substantia nigra as a site of origin of dopamine-dependent motor syndrome induced by stimulation of mu and gamma opioid receptors. Brain Res. 487:1989;120-130.
14. Parry T.J., Eberle-Wang K., Lucki I., Chesselet M.F. Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats. Exp. Neurol. 128:1994;181-190.
15. G. Paxinos, C. Watson, The Rat Brain In Stereotaxic Coordinates, 2nd ed., Academic Press, New York, 1986.
16. Rosengarten H., Schweitzer J.W., Friedhoff A.J. Induction of dyskinesias in naive rats by D1 stimulation. Life Sci. 33:1983;2479-2484.
17. Rosengarten H., Schweitzer J.W., Friedhoff A.J. Selective D2 receptor reduction enhances a D1 mediated oral dyskinesia in rats. Eur. J. Pharmacol. 134:1986;83-88.
18. Sasaki T., Kennedy J.L., Nobrega J.N. Localized changes in the GABA receptor-gated chloride channel in rat brain after long-term haloperidol: relation to vacuous chewing movements. Synapse. 25:1997;73-79.
19. Sasaki T., Kennedy J.L., Nobrega J.N. Autoradiographic mapping of mu opioid receptor changes in rat brain after long-term haloperidol: Relationship to the development of vacuous chewing movements. Psychopharmacology. 128:1996;97-104.
20. A and dopamine D-2, but dot dopamine D-1 receptors. Life Sci. 44:1989;229-236.
21. See R.E., Chapman M.A. The consequences of long-term antipsychotic drug administration on basal ganglia neuronal function in laboratory animals. Crit. Rev. Neurobiol. 8:1994;85-124.
22. See R.E., Toga A.W., Ellison G. Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and typical neuroleptics in rats. J. Neural Transm. (Gen. Sect.). 82:1990;93-109.
23. A and dopamine D1 binding site correlates of haloperidol-induced oral dyskinesias in rat. Exp. Neurol. 127:1994;62-69.
24. Stoessl A.J., Dourish C.T., Iversen S.D. Chronic neuroleptic-induced mouth movements in the rats: suppression by CCK and selective dopamine D1 and D2 antagonists. Psychopharmacology. 98:1989;372-379.
25. Waddington J.L. Behavioral correlates of the actions of selective D-1 dopamine antagonists. Biochem. Pharmacol. 35:1986;3661-3667.
26. Waddington J.L. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology. 101:1990;431-447.
27. Waddington J.L., Cross A.J., Gamble S.J., Bourne R.C. Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science. 220:1983;530-532.